7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (71%) |
| No statute on record | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIBUYA, MARK LANCE | 1 | 32.3% | +24.9% |
| MAYNARD, JOHNATHAN A | 1 | 39.9% | +7.2% |
| SCHUBERG, LAURA J | 1 | 23.7% | +36.7% |
| KIM, EUN HWA | 1 | 71.5% | +38.9% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| JAFFRI, ZEHRA | 1 | 62.7% | +47.0% |
| BUCKMASTER, MARLENE VRENI | 1 | 25.9% | +74.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17974944 | Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis | SCHUBERG, LAURA J | 38d overdue |
| 16976277 | EXOSOME TARGETING OF CD4+ EXPRESSING CELLS | BUCKMASTER, MARLENE VRENI | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17570173 | SURGICAL DRAIN REMOVAL DEVICE AND METHODS FOR USING SAME | JAFFRI, ZEHRA | 89d overdue |
| 17974944 | Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis | SCHUBERG, LAURA J | 38d overdue |
| 16976277 | EXOSOME TARGETING OF CD4+ EXPRESSING CELLS | BUCKMASTER, MARLENE VRENI | 12d |
| 18276593 | RECONSTITUTION OF EXTRACELLULAR MATRIXES FOR MUSCULOSKELETAL JOINT TISSUE REPAIR USING BIOMIMETIC BIOLOGIC AND SYNTHETIC FACTORS | SHIBUYA, MARK LANCE | 29d |
| 17997329 | SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING | KIM, EUN HWA | 30d |
| 17723271 | RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS | BLUMEL, BENJAMIN P | 35d |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 3798 | 1 |
| 3794 | 1 |
| 1671 | 1 |
| 3771 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18276593 | RECONSTITUTION OF EXTRACELLULAR MATRIXES FOR MUSCULOSKELETAL JOINT TISSUE REPAIR USING BIOMIMETIC BIOLOGIC AND SYNTHETIC FACTORS | SHIBUYA, MARK LANCE | 1631 | §103 | Non-Final OA | 29d | Pending | Aug 09, 2023 |
| 18274279 | IMAGE-BASED APPROACH TO EVALUATE CONNECTIVE TISSUE STRUCTURE, REMODELING, AND RISK OF INJURY | MAYNARD, JOHNATHAN A | 3798 | §103 | Non-Final OA | 14d | Pending | Jul 26, 2023 |
| 17974944 | Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis | SCHUBERG, LAURA J | 1631 | Other | Final Rejection | 38d overdue | Pending | Oct 27, 2022 |
| 17997329 | SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING | KIM, EUN HWA | 3794 | §103 | Non-Final OA | 30d | Pending | Oct 27, 2022 |
| 17723271 | RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS | BLUMEL, BENJAMIN P | 1671 | Other | Non-Final OA | 35d | Pending | Apr 18, 2022 |
| 17570173 | SURGICAL DRAIN REMOVAL DEVICE AND METHODS FOR USING SAME | JAFFRI, ZEHRA | 3771 | §103 | Final Rejection | 89d overdue | Pending | Jan 06, 2022 |
| 16976277 | EXOSOME TARGETING OF CD4+ EXPRESSING CELLS | BUCKMASTER, MARLENE VRENI | 1672 | §103 | Final Rejection | 12d | Pending | Aug 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial